Merck Serono and Illumina Enter Strategic Collaboration for Diagnostics in Oncology
12-Mar-2015 -
Merck Serono and Illumina, Inc., announced a collaboration to expand the development of a universal next-generation sequencing-based oncology diagnostic for clinical trials of targeted cancer therapies.
Under the terms of the agreement, Merck Serono and Illlumina will work together to develop ...
cancer
diagnostics
Merck Serono
+2